BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37828793)

  • 1. Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy.
    Sakai K; Takahashi M; Ito Y; Yamada S; Ito T; Higuchi Y; Kameda S
    Int J Rheum Dis; 2024 Jan; 27(1):e14942. PubMed ID: 37828793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins.
    Shimada T; Higashida-Konishi M; Akiyama M; Hama S; Izumi K; Matsubara S; Oshima H; Okano Y
    Immunol Med; 2022 Sep; 45(3):175-179. PubMed ID: 35389818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
    Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H
    Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
    Xu L; Yang MG; Hu L; Gao H; Ji S
    BMC Musculoskelet Disord; 2023 Mar; 24(1):219. PubMed ID: 36959614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
    Dandasena T; Ingle V; Singhai A; Saigal S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy triggered by human parvovirus B19 infection].
    Suzuki I; Nakao R; Unai Y; Miyazaki Y
    Rinsho Shinkeigaku; 2022 May; 62(5):363-368. PubMed ID: 35474284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB; Tian YR; Ma XY; Yin G; Xie Q
    Front Immunol; 2021; 12():777502. PubMed ID: 34925350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SRP immune-mediated necrotizing myopathy responsive to ofatumumab: a case report.
    Chen S; Yang J; He D; Fu J; Lai X; Zhao B; Chen X; Shang H
    Front Immunol; 2023; 14():1301109. PubMed ID: 38169756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
    Ma X; Bu BT
    Front Immunol; 2022; 13():1019972. PubMed ID: 36311711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune-Mediated Necrotizing Myopathy].
    Uruha A
    Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis.
    Kimura M; Aizawa A; Kudou R; Rikitake Y; Iwao C; Rikitake M; Iwao K; Kariya Y; Kawaguchi T; Matsuda M; Miyauchi S; Takajo I; Umekita K
    Clin Exp Rheumatol; 2024 Feb; 42(2):321-328. PubMed ID: 37497714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
    Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
    Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
    Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
    Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report.
    Belkhribchia MR; Lobrinus JA; Semlil L; Chauveau N; Ajrinija A; Egervari K; Ennhaili ZE
    J Investig Med High Impact Case Rep; 2024; 12():23247096241231646. PubMed ID: 38353222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothyroidism combined with anti-signal recognition particle immune-mediated necrotizing myopathy: A case report and review of the literature.
    Shi J; Meng H; Zhang W; Guo J
    Clin Neuropathol; 2022; 41(2):83-88. PubMed ID: 35034689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.